First Time Loading...
N

NeoPharm Co Ltd
KOSDAQ:092730

Watchlist Manager
NeoPharm Co Ltd
KOSDAQ:092730
Watchlist
Price: 25 950 KRW -1.33%
Updated: May 14, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

97.1B
+5%
Revenue
Growth Rates:
1 Year
+14%
3 Years
+19%
5 Years
+47%
7 Years
+129%
10 Years
+382%
25.3B
+4%
Operating Income
Growth Rates:
1 Year
+18%
3 Years
+16%
5 Years
+32%
7 Years
+165%
10 Years
+1 083%
23.2B
+12%
Net Income
Growth Rates:
1 Year
+36%
3 Years
+28%
5 Years
+51%
7 Years
+200%
10 Years
+1 130%

Earnings Waterfall
NeoPharm Co Ltd

Revenue
97.1B KRW
Cost of Revenue
-31.7B KRW
Gross Profit
65.4B KRW
Operating Expenses
-40.1B KRW
Operating Income
25.3B KRW
Other Expenses
-2.1B KRW
Net Income
23.2B KRW

Income Statement
NeoPharm Co Ltd

Rotate your device to view
Income Statement
Currency: KRW
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
20 137
N/A
20 843
+4%
22 287
+7%
23 371
+5%
25 603
+10%
28 237
+10%
29 133
+3%
31 947
+10%
35 965
+13%
39 325
+9%
41 999
+7%
43 097
+3%
42 369
-2%
43 164
+2%
46 739
+8%
49 765
+6%
53 634
+8%
57 174
+7%
60 236
+5%
63 144
+5%
66 275
+5%
69 501
+5%
74 864
+8%
79 611
+6%
83 240
+5%
82 680
-1%
82 617
0%
81 412
-1%
81 625
+0%
85 286
+4%
85 275
0%
86 802
+2%
87 931
+1%
87 321
-1%
87 424
+0%
86 805
-1%
85 033
-2%
86 272
+1%
89 292
+4%
92 271
+3%
97 105
+5%
Gross Profit
Cost of Revenue
(5 075)
(5 267)
(5 974)
(6 191)
(6 853)
(7 391)
(7 364)
(8 209)
(9 395)
(10 279)
(11 067)
(11 116)
(10 492)
(10 586)
(11 317)
(12 179)
(13 490)
(14 520)
(15 806)
(16 426)
(17 939)
(19 101)
(20 663)
(22 354)
(23 136)
(22 931)
(22 785)
(22 664)
(22 984)
(24 637)
(24 531)
(25 161)
(25 544)
(25 687)
(26 609)
(26 525)
(26 653)
(27 130)
(27 826)
(29 054)
(31 720)
Gross Profit
15 064
N/A
15 578
+3%
16 314
+5%
17 181
+5%
18 750
+9%
20 846
+11%
21 770
+4%
23 738
+9%
26 569
+12%
29 045
+9%
30 932
+6%
31 981
+3%
31 877
0%
32 579
+2%
35 422
+9%
37 586
+6%
40 143
+7%
42 654
+6%
44 430
+4%
46 718
+5%
48 336
+3%
50 399
+4%
54 200
+8%
57 255
+6%
60 104
+5%
59 748
-1%
59 831
+0%
58 749
-2%
58 642
0%
60 650
+3%
60 745
+0%
61 642
+1%
62 386
+1%
61 635
-1%
60 815
-1%
60 280
-1%
58 380
-3%
59 142
+1%
61 465
+4%
63 216
+3%
65 385
+3%
Operating Income
Operating Expenses
(12 923)
(12 897)
(13 829)
(12 910)
(13 747)
(14 897)
(15 871)
(18 022)
(20 311)
(23 328)
(22 390)
(22 469)
(22 323)
(22 404)
(23 930)
(25 659)
(26 106)
(27 136)
(28 184)
(29 522)
(29 174)
(30 580)
(32 715)
(34 186)
(37 144)
(37 070)
(37 696)
(38 034)
(36 739)
(38 349)
(37 733)
(38 809)
(39 955)
(39 565)
(39 903)
(38 680)
(36 941)
(37 002)
(38 001)
(38 832)
(40 078)
Selling, General & Administrative
(10 940)
(10 895)
(10 878)
(11 058)
(11 775)
(12 852)
(13 743)
(14 527)
(17 998)
(19 312)
(19 831)
(19 902)
(19 771)
(19 846)
(21 487)
(23 232)
(23 649)
(24 575)
(25 500)
(26 573)
(26 275)
(27 653)
(29 559)
(31 039)
(33 958)
(33 422)
(33 911)
(34 108)
(32 991)
(34 494)
(34 100)
(35 073)
(36 022)
(35 587)
(35 790)
(34 685)
(32 984)
(33 087)
(34 142)
(34 924)
(36 276)
Research & Development
(1 594)
(1 610)
(1 460)
(1 483)
(1 616)
(1 699)
(1 786)
(1 870)
(1 973)
(1 941)
(2 209)
(2 206)
(2 183)
(2 184)
(2 068)
(2 105)
(2 098)
(2 257)
(2 355)
(2 617)
(2 576)
(2 617)
(2 660)
(2 551)
(2 518)
(2 603)
(2 768)
(2 824)
(2 802)
(2 881)
(2 659)
(2 765)
(2 935)
(2 945)
(3 043)
(2 898)
(2 854)
(2 805)
(2 739)
(2 777)
(2 647)
Depreciation & Amortization
(389)
(391)
(381)
(369)
(356)
(346)
(341)
(338)
(340)
(341)
(351)
(361)
(369)
(377)
(376)
(364)
(358)
(344)
(329)
(331)
(323)
(326)
(497)
(579)
(667)
(800)
(791)
(877)
(947)
(974)
(971)
(967)
(999)
(1 033)
(1 070)
(1 097)
(1 103)
(1 110)
(1 120)
(1 131)
(1 155)
Other Operating Expenses
0
0
(1 110)
0
0
0
0
(1 287)
0
(1 734)
0
0
0
3
0
42
0
40
0
0
0
16
0
(17)
0
(245)
(226)
(225)
0
0
(3)
(4)
0
0
0
0
0
0
0
0
0
Operating Income
2 140
N/A
2 680
+25%
2 485
-7%
4 270
+72%
5 003
+17%
5 949
+19%
5 898
-1%
5 715
-3%
6 259
+10%
5 715
-9%
8 540
+49%
9 511
+11%
9 553
+0%
10 174
+7%
11 491
+13%
11 927
+4%
14 038
+18%
15 520
+11%
16 248
+5%
17 197
+6%
19 161
+11%
19 820
+3%
21 486
+8%
23 071
+7%
22 961
0%
22 679
-1%
22 136
-2%
20 715
-6%
21 902
+6%
22 302
+2%
23 013
+3%
22 834
-1%
22 431
-2%
22 070
-2%
20 911
-5%
21 600
+3%
21 439
-1%
22 140
+3%
23 464
+6%
24 385
+4%
25 307
+4%
Pre-Tax Income
Interest Income Expense
1 126
1 094
251
381
385
396
497
418
400
371
321
248
470
289
367
508
32
278
471
491
932
1 098
943
1 249
1 249
1 554
1 571
1 392
1 142
1 046
1 123
1 457
1 800
1 832
2 254
3 072
2 221
3 333
3 353
3 289
4 392
Non-Reccuring Items
(1 065)
(1 055)
0
(1 114)
(1 261)
(1 250)
(1 291)
0
(1 713)
0
(1 736)
(1 720)
9
7
57
0
40
0
34
50
16
0
(3)
0
(248)
0
0
0
0
(3)
0
0
(11)
(14)
(14)
(14)
(6)
(1)
(14)
(14)
(13)
Gain/Loss on Disposition of Assets
(231)
(230)
0
0
(233)
(232)
(323)
(335)
(430)
(443)
(481)
(471)
(557)
(540)
0
(409)
(41)
0
(45)
(44)
(1)
0
(1)
(2)
(7)
0
(7)
(11)
(11)
0
(10)
0
(3)
(3)
(4)
(4)
17
17
18
18
24
Total Other Income
(29)
(84)
(454)
(477)
(174)
(200)
(115)
(93)
(193)
(121)
(139)
(97)
(36)
(54)
(488)
(33)
(37)
(209)
(221)
(322)
(325)
(386)
(410)
(473)
(414)
(272)
(149)
(82)
(97)
(7)
(158)
(217)
(381)
(450)
(302)
(356)
(348)
(364)
(363)
(420)
(337)
Pre-Tax Income
1 940
N/A
2 404
+24%
2 282
-5%
3 060
+34%
3 720
+22%
4 661
+25%
4 666
+0%
5 707
+22%
4 322
-24%
5 522
+28%
6 506
+18%
7 470
+15%
9 439
+26%
9 874
+5%
11 427
+16%
11 991
+5%
14 032
+17%
15 589
+11%
16 487
+6%
17 371
+5%
19 784
+14%
20 532
+4%
22 013
+7%
23 843
+8%
23 541
-1%
23 961
+2%
23 550
-2%
22 013
-7%
22 936
+4%
23 338
+2%
23 968
+3%
24 074
+0%
23 836
-1%
23 435
-2%
22 845
-3%
24 299
+6%
23 323
-4%
25 125
+8%
26 458
+5%
27 257
+3%
29 373
+8%
Net Income
Tax Provision
(52)
(164)
(354)
(514)
(1 152)
(1 426)
(1 432)
(1 191)
(915)
(1 049)
(1 086)
(1 528)
(1 696)
(1 777)
(2 061)
(2 164)
(2 472)
(3 075)
(3 382)
(3 689)
(4 414)
(4 737)
(5 339)
(5 841)
(4 296)
(4 061)
(3 616)
(3 280)
(4 805)
(4 863)
(5 908)
(5 865)
(6 122)
(6 530)
(5 475)
(6 054)
(6 296)
(6 213)
(6 677)
(6 524)
(6 160)
Income from Continuing Operations
1 887
2 240
1 929
2 547
2 568
3 237
3 235
4 516
3 407
4 472
5 418
5 941
7 742
8 095
9 365
9 827
11 559
12 514
13 105
13 682
15 370
15 796
16 676
18 003
19 245
19 902
19 935
18 734
18 131
18 474
18 059
18 207
17 713
16 905
17 370
18 245
17 027
18 912
19 781
20 733
23 213
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
1 887
N/A
2 240
+19%
1 929
-14%
2 547
+32%
2 568
+1%
3 237
+26%
3 235
0%
4 516
+40%
3 407
-25%
4 472
+31%
5 418
+21%
5 941
+10%
7 742
+30%
8 095
+5%
9 365
+16%
9 827
+5%
11 559
+18%
12 514
+8%
13 105
+5%
13 682
+4%
15 370
+12%
15 796
+3%
16 676
+6%
18 003
+8%
19 245
+7%
19 902
+3%
19 935
+0%
18 734
-6%
18 131
-3%
18 474
+2%
18 059
-2%
18 207
+1%
17 713
-3%
16 905
-5%
17 370
+3%
18 245
+5%
17 027
-7%
18 912
+11%
19 781
+5%
20 733
+5%
23 213
+12%
EPS (Diluted)
269.57
N/A
320
+19%
275.57
-14%
363.85
+32%
366.85
+1%
462.42
+26%
462.14
0%
645.14
+40%
486.71
-25%
638.85
+31%
774
+21%
848.71
+10%
1 106
+30%
1 156.42
+5%
1 337.85
+16%
1 403.85
+5%
1 651.28
+18%
1 787.71
+8%
1 872.14
+5%
1 954.57
+4%
2 195.71
+12%
2 256.57
+3%
2 382.28
+6%
2 250.37
-6%
2 405.62
+7%
2 487.75
+3%
2 491.87
+0%
2 341.75
-6%
2 266.37
-3%
2 309.25
+2%
2 309.12
0%
2 328.13
+1%
2 264.94
-3%
2 161.61
-5%
2 221.02
+3%
2 332.89
+5%
2 177.2
-7%
2 418.16
+11%
2 529.39
+5%
2 651.08
+5%
2 968.15
+12%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.